FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,285,347 | -55.5% | 4,851,579 | -0.1% | 0.17% | -49.7% |
| Q2 2023 | $23,113,508 | -16.5% | 4,855,779 | 0.0% | 0.33% | -17.9% |
| Q1 2023 | $27,677,940 | -43.6% | 4,855,779 | -0.1% | 0.40% | -38.2% |
| Q4 2022 | $49,050,305 | -41.6% | 4,861,279 | +29.8% | 0.65% | -46.0% |
| Q3 2022 | $83,950,000 | -4.6% | 3,746,086 | +5.5% | 1.20% | -3.1% |
| Q2 2022 | $87,972,000 | -36.6% | 3,550,086 | -0.7% | 1.24% | -22.7% |
| Q1 2022 | $138,660,000 | -37.2% | 3,576,486 | -5.3% | 1.61% | -29.3% |
| Q4 2021 | $220,918,000 | +15.1% | 3,775,736 | +16.6% | 2.28% | +16.9% |
| Q3 2021 | $191,918,000 | -15.4% | 3,238,036 | +23.9% | 1.95% | -12.0% |
| Q2 2021 | $226,829,000 | +24.5% | 2,613,536 | +18.3% | 2.21% | +14.9% |
| Q1 2021 | $182,160,000 | -4.9% | 2,209,336 | +4.8% | 1.93% | -12.2% |
| Q4 2020 | $191,635,000 | +116.2% | 2,107,500 | -5.0% | 2.20% | +79.2% |
| Q3 2020 | $88,634,000 | +31.7% | 2,217,500 | +13.1% | 1.22% | +28.7% |
| Q2 2020 | $67,295,000 | +93.8% | 1,961,400 | +25.5% | 0.95% | +41.5% |
| Q1 2020 | $34,719,000 | +2043.1% | 1,563,200 | +1787.9% | 0.67% | +2488.5% |
| Q4 2019 | $1,620,000 | +73.6% | 82,800 | +37.8% | 0.03% | +52.9% |
| Q3 2019 | $933,000 | -22.1% | 60,100 | +1.9% | 0.02% | -15.0% |
| Q2 2019 | $1,198,000 | – | 59,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |